Clinicopathological features of SMARCA4-deficient tumors.
10.3760/cma.j.cn112151-20220226-00131
- Author:
Pei Pei ZHU
1
;
Xin Xing LI
2
;
Jia Han LIU
3
;
Xiu Luan DU
4
;
Hai Yan SU
5
;
Jian WANG
3
Author Information
1. Department of Pathology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
2. Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
3. Department of Pathology, Fudan University, Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai 200032, China.
4. Department of Pathology, the Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University, Suzhou 215153, China.
5. Department of Pathology, Zhangzhou Municipal Hospital of Fujian Medical University, Zhangzhou 363000, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers, Tumor;
DNA Helicases;
Humans;
Neoplasms;
Nuclear Proteins/genetics*;
Transcription Factors
- From:
Chinese Journal of Pathology
2022;51(8):792-798
- CountryChina
- Language:Chinese
